GE Healthcare launches Xuri™ MSC Medium and Attachment Solution for serum-free and xeno-free expansion of human mesenchymal stem cells
Xuri™ MSC Medium is a versatile and reliable cell culture product that enables the safe and efficient expansion of human mesenchymal stem cells (hMSC) without the use of animal derived components or undefined serum. It can be used to culture hMSC from a range of sources, including bone marrow, umbilical cord, or adipose tissue.
Compared to serum-facilitated cultivation, Xuri MSC Medium achieves a higher yield of multipotent cells in a single passage, thereby reaching the desired cell dose for patient treatment in a shorter timescale. Removing the need for lengthy batch validation and risk assessment associated with serum also enables a faster and more cost effective process.
Xeno-Free Xuri MSC Attachment Solution is the recommended coating agent for the serum-free expansion of hMSC with Xuri MSC Medium and supports high reproducibility across batches.
Xuri products are supplied with a comprehensive documentation support package that follows USP <1043> requirements applicable to a supplier on ancillary material for cell, gene and tissue-engineered products. All human components included in the product undergo extensive testing in accordance with regulatory requirements.
For further information please visit:
https://promo.gelifesciences.com/GL/XURI/expansion.html
Issued for and on behalf of GE Healthcare by Instinctif Partners.
For more information or a high resolution image please contact:
Contact
Instinctif Partners
Tim Watson / Cora Kaiser
T +44 (0)20 7866 7861 / +49 (0)89 3090 5189 11
E GE-CellTherapyTechnologies@instinctif.com

